S&P 500   3,959.80 (-0.09%)
DOW   33,687.71 (-0.28%)
QQQ   284.41 (+0.20%)
AAPL   144.11 (+1.02%)
MSFT   246.96 (-0.18%)
META   116.73 (+1.21%)
GOOGL   93.42 (-0.31%)
AMZN   89.59 (-0.84%)
TSLA   181.50 (+4.65%)
NVDA   173.32 (+0.95%)
NIO   12.86 (-4.10%)
BABA   92.32 (-1.96%)
AMD   69.64 (-1.18%)
T   19.19 (+0.37%)
MU   55.52 (+0.58%)
CGC   2.93 (-5.18%)
F   13.22 (+0.76%)
GE   82.27 (-1.63%)
DIS   93.96 (+1.52%)
AMC   5.82 (-4.12%)
PYPL   74.18 (-0.05%)
PFE   51.90 (+0.23%)
NFLX   323.76 (+4.35%)
S&P 500   3,959.80 (-0.09%)
DOW   33,687.71 (-0.28%)
QQQ   284.41 (+0.20%)
AAPL   144.11 (+1.02%)
MSFT   246.96 (-0.18%)
META   116.73 (+1.21%)
GOOGL   93.42 (-0.31%)
AMZN   89.59 (-0.84%)
TSLA   181.50 (+4.65%)
NVDA   173.32 (+0.95%)
NIO   12.86 (-4.10%)
BABA   92.32 (-1.96%)
AMD   69.64 (-1.18%)
T   19.19 (+0.37%)
MU   55.52 (+0.58%)
CGC   2.93 (-5.18%)
F   13.22 (+0.76%)
GE   82.27 (-1.63%)
DIS   93.96 (+1.52%)
AMC   5.82 (-4.12%)
PYPL   74.18 (-0.05%)
PFE   51.90 (+0.23%)
NFLX   323.76 (+4.35%)
S&P 500   3,959.80 (-0.09%)
DOW   33,687.71 (-0.28%)
QQQ   284.41 (+0.20%)
AAPL   144.11 (+1.02%)
MSFT   246.96 (-0.18%)
META   116.73 (+1.21%)
GOOGL   93.42 (-0.31%)
AMZN   89.59 (-0.84%)
TSLA   181.50 (+4.65%)
NVDA   173.32 (+0.95%)
NIO   12.86 (-4.10%)
BABA   92.32 (-1.96%)
AMD   69.64 (-1.18%)
T   19.19 (+0.37%)
MU   55.52 (+0.58%)
CGC   2.93 (-5.18%)
F   13.22 (+0.76%)
GE   82.27 (-1.63%)
DIS   93.96 (+1.52%)
AMC   5.82 (-4.12%)
PYPL   74.18 (-0.05%)
PFE   51.90 (+0.23%)
NFLX   323.76 (+4.35%)
S&P 500   3,959.80 (-0.09%)
DOW   33,687.71 (-0.28%)
QQQ   284.41 (+0.20%)
AAPL   144.11 (+1.02%)
MSFT   246.96 (-0.18%)
META   116.73 (+1.21%)
GOOGL   93.42 (-0.31%)
AMZN   89.59 (-0.84%)
TSLA   181.50 (+4.65%)
NVDA   173.32 (+0.95%)
NIO   12.86 (-4.10%)
BABA   92.32 (-1.96%)
AMD   69.64 (-1.18%)
T   19.19 (+0.37%)
MU   55.52 (+0.58%)
CGC   2.93 (-5.18%)
F   13.22 (+0.76%)
GE   82.27 (-1.63%)
DIS   93.96 (+1.52%)
AMC   5.82 (-4.12%)
PYPL   74.18 (-0.05%)
PFE   51.90 (+0.23%)
NFLX   323.76 (+4.35%)
NASDAQ:CNTG

Centogene - CNTG News Today

$0.72
-0.04 (-5.26%)
(As of 12/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.71
$0.77
50-Day Range
$0.72
$1.28
52-Week Range
$0.68
$6.20
Volume
63,018 shs
Average Volume
30,130 shs
Market Capitalization
$19.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.25
Get Centogene News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNTG and its competitors with MarketBeat's FREE daily newsletter.



CNTG Media Mentions By Week

CNTG Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CNTG
News Sentiment

0.00

0.44

Average
Medical
News Sentiment

CNTG News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CNTG Articles
This Week

0

1

CNTG Articles
Average Week

SourceHeadline
finance.yahoo.com logoCENTOGENE to Participate in Upcoming Conferences in December
finance.yahoo.com - December 1 at 4:48 PM
MarketBeat logoCentogene (NASDAQ:CNTG) Expected to Post Q3 2022 Earnings of ($0.40) Per Share
americanbankingnews.com - November 29 at 1:14 AM
finance.yahoo.com logoAnalyst: Centogene Leveraging The Largest BioDatabank For Rare Diseases
finance.yahoo.com - November 23 at 7:27 PM
finance.yahoo.com logoCENTOGENE Announces Changes to Supervisory Board, Including Appointment of Mary Sheahan
finance.yahoo.com - November 21 at 10:37 AM
finance.yahoo.com logoCENTOGENE to Participate in Upcoming Conferences in November
finance.yahoo.com - November 10 at 6:40 PM
finance.yahoo.com logoCENTOGENE Launches Rare and Neurodegenerative Disease Biodata Network
finance.yahoo.com - November 3 at 1:43 PM
finance.yahoo.com logoCENTOGENE to Participate in Upcoming Partnering Conferences in October
finance.yahoo.com - October 6 at 10:06 AM
marketwatch.com logoCENTOGENE Reaches 12,500 Patient Milestone in World's Largest Observational Study on Parkinson's Disease Genetics
marketwatch.com - October 5 at 7:12 PM
finance.yahoo.com logoCENTOGENE Reaches 12,500 Patient Milestone in World’s Largest Observational Study on Parkinson’s Disease Genetics
finance.yahoo.com - October 3 at 12:33 PM
finance.yahoo.com logoCENTOGENE to Present at Upcoming Investor & Partnering Conferences in September
finance.yahoo.com - September 1 at 11:18 AM
reuters.com logoCNTG.O - Centogene NV | Stock Price & Latest News | Reuters
reuters.com - August 16 at 7:20 PM
finance.yahoo.com logoCENTOGENE Reports First Quarter 2022 Financial Results
finance.yahoo.com - July 15 at 1:02 PM
seekingalpha.com logoCentogene appoints Miguel Coego Rios as chief financial officer - Seeking Alpha
seekingalpha.com - June 27 at 9:41 PM
finance.yahoo.com logoCENTOGENE Announces Appointment of Miguel Coego Rios as Chief Financial Officer
finance.yahoo.com - June 27 at 4:34 PM
finance.yahoo.com logoCENTOGENE Announces Shareholder Approval of All Resolutions at 2022 Annual General Meeting
finance.yahoo.com - June 27 at 4:34 PM
streetinsider.com logoForm 6-K Centogene NV For: Jun 13 - StreetInsider.com
streetinsider.com - June 13 at 11:04 AM
globenewswire.com logoCENTOGENE and Agios Expand Partnership for Clinical Development of PYRUKYND® (mitapivat) to Treat Children With Rare Blood Disease - GlobeNewswire
globenewswire.com - June 13 at 11:04 AM
investing.com logoCentogene B V (CNTG)
investing.com - June 10 at 8:47 AM
globenewswire.com logoGlobal Biomarkers Market Outlook & Forecast Report 2022-2027 - Key Vendors are Abbott, BioMerieux, Biohit, CENTOGENE, Creative Diagnostics F. Hoffmann-La Roche, Fujirebio, General Electric, TAmiRNA - GlobeNewswire
globenewswire.com - June 6 at 4:29 AM
nasdaq.com logoPhreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates - Nasdaq
nasdaq.com - June 2 at 9:00 PM
seekingalpha.com logoCentogene gets CE marking in EU for cloud-based software platform (NASDAQ:CNTG) - Seeking Alpha
seekingalpha.com - May 27 at 7:59 AM
globenewswire.com logoCENTOGENE's CentoCloud® Is Now CE-Marked as One of the Only Decentralized SaaS Platforms Compliant With European IVD Regulatory Framework - GlobeNewswire
globenewswire.com - May 25 at 6:35 AM
globenewswire.com logoCENTOGENE Contributes to Europe-Wide Efforts to Update Guidelines for Whole Genome Sequencing (WGS) in Rare Disease Diagnostics - GlobeNewswire
globenewswire.com - May 23 at 7:08 AM
globenewswire.com logoCENTOGENE to Present at the HC Wainwright Global Investment Conference - GlobeNewswire
globenewswire.com - May 19 at 3:28 PM
finance.yahoo.com logoCentogene (NASDAQ:CNTG) investors are sitting on a loss of 66% if they invested a year ago - Yahoo Finance
finance.yahoo.com - May 6 at 6:11 PM
finance.yahoo.com logoCentogene (NASDAQ:CNTG) investors are sitting on a loss of 66% if they invested a year ago
finance.yahoo.com - May 6 at 1:08 PM
benzinga.com logoCentogene Reports Extension Of Market Access, Expansion Of Partnership With Takeda To Advance Patient Car - Benzinga
benzinga.com - April 28 at 10:48 AM
globenewswire.com logoCENTOGENE and Takeda Extend Market Access and Expansion Partnership to Advance Patient Care Globally - GlobeNewswire
globenewswire.com - April 28 at 10:48 AM
finance.yahoo.com logoUnited States non-invasive prenatal testing (NIPT) market size to amass USD 2557 million by 2030 - Yahoo Finance
finance.yahoo.com - April 14 at 8:22 AM
globenewswire.com logoEuropean Clinical Laboratory Services Growth Opportunities: On-demand Digital Diagnostic Services for Improved Access and Personalized Healthcare - GlobeNewswire
globenewswire.com - April 14 at 8:22 AM
globenewswire.com logoCENTOGENE Reports Fourth Quarter and Full Year 2021 Financial Results - GlobeNewswire
globenewswire.com - April 1 at 5:09 PM
nasdaq.com logoThese 2 Blue Chip Stocks Just Hit All-Time Highs - Nasdaq
nasdaq.com - March 31 at 12:00 AM
nasdaq.com logoWhy Lithium Americas Stock Just Jumped 12% - Nasdaq
nasdaq.com - March 30 at 6:48 PM
fool.com logoCentogene N.V. (CNTG) Q4 2021 Earnings Call Transcript
fool.com - March 30 at 1:21 PM
finance.yahoo.com logoCENTOGENE Reports Fourth Quarter and Full Year 2021 Financial Results
finance.yahoo.com - March 30 at 9:30 AM
benzinga.com logoCentogene's Earnings: A Preview - Benzinga - Benzinga
benzinga.com - March 29 at 6:25 PM
finance.yahoo.com logoNext-Generation Gynecological Cancer Diagnostics Market - A Global Market and Regional Analysis: Focus on Technology, Product Type, End User, and Country Analysis - Analysis and Forecast, 2020-2031 - Yahoo Finance
finance.yahoo.com - March 28 at 6:47 AM
finance.yahoo.com logoGlobal Immune Checkpoint Inhibitors Biomarkers & Clinical Trials Report 2022: Featuring Profiles of Key Players Roche, Abbott, Thermo Fisher Scientific, Centogene and Myriad - Yahoo Finance
finance.yahoo.com - March 25 at 4:01 PM
globenewswire.com logoCENTOGENE CEO Kim Stratton to Speak at BIO-Europe Spring® 2022 Conference - GlobeNewswire
globenewswire.com - March 24 at 7:37 AM
finance.yahoo.com logoCENTOGENE CEO Kim Stratton to Speak at BIO-Europe Spring® 2022 Conference
finance.yahoo.com - March 24 at 7:37 AM
nasdaq.com logoPre-market Movers: ZTEK, LBPS, ALLG, CNTG, GAN… - Nasdaq
nasdaq.com - March 23 at 4:36 PM
finance.yahoo.com logoBIS Research Study Highlights the Global Precision Cardiology Market to Reach $3.58 billion by 2031 - Yahoo Finance
finance.yahoo.com - March 17 at 5:42 PM
globenewswire.com logoCENTOGENE Announces Expansion of Data Access and - GlobeNewswire
globenewswire.com - March 17 at 5:42 PM
finance.yahoo.com logoCENTOGENE Announces Expansion of Data Access and Collaboration Agreement With Pfizer
finance.yahoo.com - March 17 at 5:42 PM
benzinga.com logoGlobal Immune Checkpoint Inhibitors $30 Billion Market Opportunity - Benzinga
benzinga.com - March 15 at 7:50 AM
finance.yahoo.com logoCENTOGENE Announces Voting Results of Extraordinary General Meeting - Yahoo Finance
finance.yahoo.com - February 22 at 4:59 PM
finance.yahoo.com logoPrenatal Testing & Newborn Screening Global Market Report 2022 - Yahoo Finance
finance.yahoo.com - February 14 at 8:42 AM
globenewswire.com logoCENTOGENE Announces CFO Transition and Appointment of - GlobeNewswire
globenewswire.com - February 8 at 11:06 AM
finance.yahoo.com logoCENTOGENE Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance & Legal and Interim CFO
finance.yahoo.com - February 8 at 11:06 AM
globenewswire.com logoGlobal Carrier Screening Market (2021 to 2031) - Featuring Myriad Genetics, Natera and OPKO Health Among Others - GlobeNewswire
globenewswire.com - February 2 at 9:42 AM
Get Centogene News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNTG and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:CNTG) was last updated on 12/9/2022 by MarketBeat.com Staff